Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.43 |
| ▸ | PDE2A | O00408 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13618121 | 0.82 | MAOB (0.46) | MAOBABCB1PDE2AAPPMAPT | |
| SCHEMBL8264411 | 0.81 | MAOB (0.44) | MAOBABCB1PDE2AAPPMAPT | |
| SCHEMBL8265170 | 0.81 | MAOB (0.48) | MAOBABCB1PDE2AAPPMAPT | |
| SCHEMBL2632843 | 0.80 | TRPV3 (0.56) | MAOBTSHRMAPK1TRPV3MAPT | |
| SCHEMBL78450 | 0.78 | MAOB (0.43) | MAOBABCB1PDE2AAPPMAPT | |
| SCHEMBL8262885 | 0.77 | ENPP2 (0.47) | MAOBABCB1PDE2AAPPPIK3CD | |
| SCHEMBL217520 | 0.75 | KDM1A (0.45) | MAOB | |
| SCHEMBL12641680 | 0.73 | MAPK8 (0.49) | MAPK1TRPV3SMN1; SMN2 | |
| SCHEMBL26707541 | 0.73 | TRPV3 (0.37) | ABCB1TRPV3 | |
| SCHEMBL91264 | 0.73 | MAOB (0.67) | MAOBABCB1APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129538-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-06 | — | — | US | disclosed |